HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 170 filers reported holding HAEMONETICS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $141,337 | -98.8% | 1,708 | -98.9% | 0.00% | -98.6% |
| Q4 2022 | $11,797,185 | +153.4% | 149,996 | +138.5% | 0.07% | +165.4% |
| Q3 2022 | $4,656,000 | +81.3% | 62,894 | +59.6% | 0.03% | +62.5% |
| Q2 2022 | $2,568,000 | +199.3% | 39,403 | +190.3% | 0.02% | +128.6% |
| Q1 2022 | $858,000 | -74.1% | 13,571 | -78.3% | 0.01% | -78.1% |
| Q4 2021 | $3,315,000 | +144.6% | 62,506 | +225.6% | 0.03% | +88.2% |
| Q3 2021 | $1,355,000 | -68.4% | 19,197 | -70.2% | 0.02% | -64.6% |
| Q2 2021 | $4,286,000 | -13.8% | 64,321 | +43.5% | 0.05% | -25.0% |
| Q1 2021 | $4,975,000 | +690.9% | 44,812 | +746.5% | 0.06% | +611.1% |
| Q4 2020 | $629,000 | -53.0% | 5,294 | -65.4% | 0.01% | -55.0% |
| Q3 2020 | $1,337,000 | -91.6% | 15,320 | -91.4% | 0.02% | -92.7% |
| Q2 2020 | $15,928,000 | +9269.4% | 177,846 | +10343.1% | 0.28% | +5400.0% |
| Q1 2020 | $170,000 | -94.1% | 1,703 | -93.2% | 0.01% | -90.6% |
| Q4 2019 | $2,888,000 | +153.3% | 25,131 | +178.1% | 0.05% | +130.4% |
| Q3 2019 | $1,140,000 | +16185.7% | 9,036 | +16035.7% | 0.02% | – |
| Q2 2019 | $7,000 | -99.1% | 56 | -99.4% | 0.00% | -100.0% |
| Q1 2019 | $773,000 | +544.2% | 8,834 | +638.6% | 0.02% | +316.7% |
| Q4 2018 | $120,000 | -64.8% | 1,196 | -59.8% | 0.01% | -68.4% |
| Q3 2018 | $341,000 | -86.7% | 2,973 | -89.6% | 0.02% | -85.3% |
| Q2 2018 | $2,564,000 | +1316.6% | 28,594 | +1055.3% | 0.13% | +1072.7% |
| Q1 2018 | $181,000 | -65.2% | 2,475 | -72.4% | 0.01% | -60.7% |
| Q4 2017 | $520,000 | +33.7% | 8,961 | +3.3% | 0.03% | +27.3% |
| Q3 2017 | $389,000 | +49.6% | 8,677 | +31.6% | 0.02% | +29.4% |
| Q2 2017 | $260,000 | -36.6% | 6,595 | -35.4% | 0.02% | -48.5% |
| Q4 2016 | $410,000 | +130.3% | 10,207 | +107.4% | 0.03% | +200.0% |
| Q3 2016 | $178,000 | -72.6% | 4,922 | -78.0% | 0.01% | -71.1% |
| Q2 2016 | $650,000 | +123.4% | 22,405 | +148.8% | 0.04% | +153.3% |
| Q3 2015 | $291,000 | +3.2% | 9,006 | +32.0% | 0.02% | +7.1% |
| Q2 2015 | $282,000 | -2.1% | 6,822 | -11.3% | 0.01% | -12.5% |
| Q4 2014 | $288,000 | +12.9% | 7,694 | +5.4% | 0.02% | 0.0% |
| Q3 2014 | $255,000 | -23.9% | 7,300 | -23.2% | 0.02% | -20.0% |
| Q2 2014 | $335,000 | – | 9,503 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |